Seyfarth Represents Nanosphere in Sale to Luminex

Seyfarth Shaw LLP represented Nanosphere, Inc., a leader in the molecular microbiology and molecular diagnostic market, in its sale to Luminex Corporation in a cash transaction worth about $115 million (including debt).

Luminex is committed to applying its passion for innovation toward creating breakthrough solutions to improve health and advance science. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories, as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. With its focus on the molecular microbiology segment, Nanosphere delivers proprietary diagnostic tools that enable rapid and accurate detection of respiratory, gastroenteric and bloodstream infections.

The cross-departmental, multiple-office Seyfarth team was led by partner Blake Hornick and included Michael Dunn, Mary Lovely, Marc Reiser, Brandon Bigelow, William Prickett, Lisa Haines and Andrew Stark.